|
Understanding IDH mutant gliomas
|
ZIA BC 011841
|
$67,687
|
$67,687
|
Wu, Jing
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$379,286
|
$75,857
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Transcriptional regulation of inflammatory and autoimmune responses
|
ZIA BC 011765
|
$435,190
|
$435,190
|
Lazarevic, Vanja
|
CCR (NCI)
|
|
TNF Signaling, Cell Death and Cancer
|
ZIA SC 010376
|
$835,691
|
$584,983
|
Liu, Zheng-Gang
|
CCR (NCI)
|
|
Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
|
ZIA BC 010801
|
$969,834
|
$727,375
|
Widemann, Brigitte
|
CCR (NCI)
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$826,126
|
$660,901
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression
|
ZIA BC 010015
|
$349,862
|
$262,396
|
Wang, Ji Ming
|
CCR (NCI)
|
|
The International DIPG Registry
|
ZIA BC 011407
|
$9,620
|
$9,620
|
Warren, Katherine
|
CCR (NCI)
|
|
The Hippo Pathway in Human Gliomas
|
ZIA BC 011649
|
$158,321
|
$158,321
|
Stommel, Jayne
|
CCR (NCI)
|
|
The effect of therapeutics on mutated IDH1 cell lines and mice tumor models
|
ZIA BC 011707
|
$122,487
|
$122,487
|
Larion, Mioara
|
CCR (NCI)
|
|
The DIPG All-In Initiative
|
ZIA BC 011833
|
$221,264
|
$221,264
|
Warren, Katherine
|
CCR (NCI)
|
|
TEDDI-R in PCNSL
|
ZIA BC 011654
|
$169,203
|
$160,743
|
Wilson, Wyndham
|
CCR (NCI)
|
|
Targeting the Kinome in Neurofibromatosis type 1
|
5R01CA142928-09
|
$434,625
|
$434,625
|
CHERNOFF, JONATHAN
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Targeted and untargeted metabolomics in IDH1 mutated xenografts in mice
|
ZIA BC 011708
|
$122,487
|
$122,487
|
Larion, Mioara
|
CCR (NCI)
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$659,879
|
$65,988
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Studies of amplification in rhabdomyosarcoma
|
ZIA BC 011378
|
$358,849
|
$35,885
|
Barr, Frederic
|
CCR (NCI)
|
|
Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells
|
ZIA BC 011777
|
$32,855
|
$6,900
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
Single-cell DNA methylation analysis of human cancer
|
ZIA BC 011846
|
$218,409
|
$174,727
|
Aldape, Kenneth
|
CCR (NCI)
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$474,287
|
$166,001
|
Daar, Ira
|
CCR (NCI)
|
|
Signal Transduction Events and the Regulation of Cell Growth
|
ZIC SC 006743
|
$553,334
|
$49,800
|
Trepel, Jane
|
CCR (NCI)
|
|
Schwann Cell Reprogramming and Cancer Perineural Invasion
|
5R01CA219534-02
|
$576,166
|
$576,166
|
WONG, RICHARD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIA BC 010391
|
$587,337
|
$176,201
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis
|
ZIA BC 011431
|
$435,190
|
$435,190
|
Lazarevic, Vanja
|
CCR (NCI)
|
|
Role of Shh in developmental patterning and growth of digit skeleton
|
ZIA BC 011118
|
$320,272
|
$32,027
|
Mackem, Susan
|
CCR (NCI)
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIA BC 010390
|
$602,021
|
$602,021
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of Formylpeptide Receptors in Host Defense
|
ZIA BC 010725
|
$349,862
|
$174,931
|
Wang, Ji Ming
|
CCR (NCI)
|
|
Role of Brachyury in regulating notochord development and neoplasia
|
ZIA BC 011121
|
$106,757
|
$42,703
|
Mackem, Susan
|
CCR (NCI)
|
|
Research and Development of Effective Therapies for Patients with Rare Tumors
|
ZIA SC 010354
|
$646,556
|
$64,656
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Relationship between DNA damage detection and signaling
|
ZIA BC 010959
|
$1,309,141
|
$654,570
|
Nussenzweig, Andre
|
CCR (NCI)
|
|
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
|
ZIA BC 010788
|
$756,068
|
$718,265
|
Thiele, Carol
|
CCR (NCI)
|
|
Regulation of Ciliogenesis and Ciliary-related signaling
|
ZIA BC 011398
|
$1,100,630
|
$110,063
|
Westlake, Christopher
|
CCR (NCI)
|
|
Rare Tumor Patient Engagement Network - Cures
|
ZID BC 011856
|
$286,416
|
$143,208
|
Dahut, William
|
CCR (NCI)
|
|
Rare Central Nervous System Cancers Initiative
|
ZIA BC 011643
|
$305,175
|
$305,175
|
Gilbert, Mark
|
CCR (NCI)
|
|
Radiation-induced translational control of gene expression
|
ZIA BC 011373
|
$515,574
|
$464,017
|
Tofilon, Philip
|
CCR (NCI)
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$5,352,849
|
$856,456
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Preclinical Modelling and Therapeutic Development for Other Cancer Indications
|
ZIA BC 011848
|
$112,660
|
$67,596
|
Sharan, Shyam
|
CCR (NCI)
|
|
Preclinical evaluation of novel therapeutics for CNS tumor therapy
|
ZIA BC 011340
|
$404,047
|
$363,642
|
Warren, Katherine
|
CCR (NCI)
|
|
Pre-clinical Translational Research Facility
|
ZIC BC 011641
|
$1,395,088
|
$1,395,088
|
Gilbert, Mark
|
CCR (NCI)
|
|
Postmortem Pathology
|
ZIC BC 010685
|
$715,711
|
$71,571
|
Kleiner, David
|
CCR (NCI)
|
|
Physiological and pathological functions of E3 ubiquitin ligases Smurfs
|
ZIA BC 011168
|
$605,099
|
$181,530
|
Zhang, Ying
|
CCR (NCI)
|
|
Phospholipid and Sphingolipid Signaling in Drosophila
|
ZIA BC 010331
|
$169,912
|
$169,912
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas
|
ZIA BC 010580
|
$9,620
|
$9,620
|
Warren, Katherine
|
CCR (NCI)
|
|
Phase II trial of mTORC1/mTORC2 inhibitor AZD2014 for sporadic meningioma
|
5R01CA201130-03
|
$401,040
|
$401,040
|
RAMESH, VIJAYA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Phase I Trial of Radiation and Lenalidomide in Pediatric Malignant Glioma
|
ZIA BC 011298
|
$19,240
|
$19,240
|
Warren, Katherine
|
CCR (NCI)
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 011516
|
$3,462,501
|
$1,385,000
|
Glod, John
|
CCR (NCI)
|
|
Pediatric Oncology Branch Behavioral Science Core
|
ZID BC 011517
|
$865,625
|
$865,625
|
Glod, John
|
CCR (NCI)
|
|
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
|
ZIA BC 010789
|
$407,114
|
$407,114
|
Thiele, Carol
|
CCR (NCI)
|
|
Outcomes and Risk of Rare Tumors
|
ZIA BC 011837
|
$138,734
|
$138,734
|
Armstrong, Terri
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$396,445
|
$39,644
|
Bottaro, Donald
|
CCR (NCI)
|
|
Noninvasive Evaluation of Pediatric CNS Tumors/RAPNO
|
ZIA BC 011299
|
$48,101
|
$48,101
|
Warren, Katherine
|
CCR (NCI)
|
Total relevant funding to Nervous System for this search: $35,178,270
|